INS CD-ALLERGENIC SUPPLEMENTS

104th Regular Session Introduced by Darby Hills

The bill would establish labeling, safety, and oversight requirements for allergenic dietary supplements to improve transparency and consumer protection.

Referred to Assignments

Summary of SB 4182 (104th Illinois General Assembly)

Purpose and intent

The bill, titled “INS CD-ALLERGENIC SUPPLEMENTS,” appears to address regulatory or policy changes related to allergenic dietary supplements. The available information indicates it is in the early stage of the legislative process (first reading and referral to assignments) and lists Sen. Darby Hills as the sponsor with a co-sponsor also being Darby Hills.

Based on the title, the legislation likely seeks to establish or modify requirements around allergenic supplements, potentially involving labeling, consumer safety, production standards, or oversight. The exact policy objectives (e.g., consumer protection, manufacturing standards, disclosure requirements) are not explicitly stated in the provided action history.

Key provisions and changes (as implied by title and standard bill structure)

While the precise text is not provided in the action history, typical provisions for a bill with a title like INS CD-ALLERGENIC SUPPLEMENTS may include:

Definitions related to allergenic dietary supplements (e.g., what constitutes an allergenic supplement, list of common allergens).
Labeling requirements, including disclosure of ingredients, potential cross-contamination risks, and allergen warnings.
Standards for manufacturing practices, testing, and quality control to ensure product safety.
Compliance deadlines or phased implementation for manufacturers and distributors.
Enforcement mechanisms, penalties for noncompliance, and authorizations for appropriate Illinois Department or agency oversight.
Consumer protections, effective date(s) for the new requirements.

Note: The exact provisions, thresholds, and timelines would be detailed in the bill text. The summary below reflects typical elements found in similar regulatory bills addressing allergenic dietary supplements.

Who would be affected

Manufacturers, distributors, and retailers of allergenic dietary supplements in Illinois would likely be directly impacted, as they may need to adjust labeling, testing, and supply-chain documentation.

Consumers of dietary supplements could gain enhanced protection through clearer allergen disclosures and improved safety information.

State regulatory agencies (e.g., the relevant health or consumer protection department) would assume or expand oversight, compliance checks, and enforcement activities.

Potentially third-party labs and testing facilities involved in quality assurance for supplements.

Procedural and timeline aspects

Status: Filed with Secretary and assigned to committee (Assignments) on March 24, 2026.

Next steps typically include committee assignment debates, potential amendment, and consideration by the full Senate, followed by a House counterpart if the bill progresses.

If enacted, the bill would likely specify an effective date, with phased or immediate implementation depending on the final text.

Practical considerations for readers

For stakeholders (manufacturers, retailers, and consumer advocates): monitor forthcoming committee hearings and amendments to understand exact requirements, compliance timelines, and enforcement details.

For consumers: the bill’s passage could improve transparency around allergen content and reduce allergy-related risks associated with dietary supplements.

If you’d like, I can incorporate the bill’s exact text and draft provisions once the official bill language is available, and refine the summary to reflect precise requirements, deadlines, and penalties.